The FDA Gets Tough Questions About Hydroxychloroquine From Republican Senators
26th August 2020
The debate over hydroxychloroquine has faded from the forefront as big tech has worked to suppress information and silence the voices of doctors and researchers promoting it. However, it appears the controversy over the drug has encouraged some senators to take a closer look, and it seems they are asking the FDA the right questions.